Sravanth K. Hindupur
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Deciphering the phenotypic responses to 177Lu-based radioligand therapy to identify efficacious combinations.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 20, 2026
Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma.
Journal: BMC genomics
Published: March 11, 2021
LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.
Journal: Nature communications
Published: May 01, 2019
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.
Journal: Cell reports
Published: June 22, 2018
Network-based integration of multi-omics data for prioritizing cancer genes.
Journal: Bioinformatics (Oxford, England)
Published: November 28, 2017
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.
Journal: Cell death & disease
Published: May 08, 2017
The protein histidine phosphatase LHPP is a tumour suppressor.
Journal: Nature
Published: March 07, 2017
Syrosingopine sensitizes cancer cells to killing by metformin.
Journal: Science advances
Published: July 28, 2016
The opposing actions of target of rapamycin and AMP-activated protein kinase in cell growth control.
The opposing actions of target of rapamycin and AMP-activated protein kinase in cell growth control.
Journal: Cold Spring Harbor perspectives in biology
Published: August 05, 2015
Last Updated: 09/26/2026